DOI:
10.1055/s-00026982
Urologie Scan
LinksClose Window
References
Hammers HJ, Plimack ER, Infante JR et al.
Expanded cohort results from CheckMate 016: A phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC).
J Clin Oncol 2015;
33 (Suppl.): Abstract 4516
We do not assume any responsibility for the contents of the web pages of other providers.